Literature DB >> 28396277

Duodenoscope reprocessing surveillance with adenosine triphosphate testing and terminal cultures: a clinical pilot study.

Kavel Visrodia1, Yuri Hanada1, Kelly M Pennington1, Pritish K Tosh2, Mark D Topazian1, Bret T Petersen1.   

Abstract

BACKGROUND AND AIMS: Recent reports of infectious outbreaks linked to duodenoscopes have led to proposals for duodenoscope surveillance culturing, which has inherent limitations. We aimed to assess the feasibility of real-time adenosine triphosphate (ATP) testing after manual cleaning and its ability to predict reprocessing adequacy, as determined by terminal duodenoscope cultures.
METHODS: Clinically used duodenoscopes underwent reprocessing per current guidelines. After manual cleaning, ATP samples were obtained from the elevator, within the proximal biopsy port, and by flushing of the biopsy channel. After high-level disinfection (HLD), aerobic cultures of the elevator and biopsy channel were obtained using sterile technique. Duodenoscopes with any ATP sample ≥200 relative light units underwent repeated cycles of cleaning, ATP testing, HLD, and terminal culturing.
RESULTS: Twenty clinically used duodenoscopes were included; 18 underwent a second reprocessing cycle, and 6 underwent a third reprocessing cycle because of detection of high ATP. After the initial reprocessing cycle, 12 of 20 (60%) duodenoscopes had positive culture results, most commonly yielding gram-negative bacilli (GNB, n = 11 from 9 duodenoscopes), and catalase-positive gram-positive cocci (CP-GPC, n = 7 from 7 duodenoscopes), suggesting staphylococcal organisms. Ambient environmental controls also showed GNB and CP-GPC growth. The overall sensitivity and specificity of ATP testing compared with terminal cultures were 30% and 53%, respectively.
CONCLUSIONS: ATP sampling appears to correlate poorly with terminal culture results and cannot be recommended as a surrogate for terminal cultures. The performance and interpretation of cultures remains complicated by the potential recovery of environmental contaminants.
Copyright © 2017 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28396277     DOI: 10.1016/j.gie.2017.03.1544

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  6 in total

1.  Scoping the scope: endoscopic evaluation of endoscope working channels with a new high-resolution inspection endoscope (with video).

Authors:  Monique T Barakat; Mohit Girotra; Robert J Huang; Subhas Banerjee
Journal:  Gastrointest Endosc       Date:  2018-02-06       Impact factor: 9.427

2.  Turbulent fluid flow is a novel closed-system sample extraction method for flexible endoscope channels of various inner diameters.

Authors:  Seo Yean Sohn; Michelle J Alfa; Richard Lai; Yacoob Tabani; Mohamed E Labib
Journal:  J Microbiol Methods       Date:  2019-11-20       Impact factor: 2.363

Review 3.  Duodenoscope-associated infection prevention: A call for evidence-based decision making.

Authors:  Cori L Ofstead; Brandy L Buro; Krystina M Hopkins; John E Eiland; Harry P Wetzler; David R Lichtenstein
Journal:  Endosc Int Open       Date:  2020-11-17

4.  No relation between adenosine triphosphate after manual cleaning and presence of microorganisms on endoscopes after automated high-level disinfection.

Authors:  Judith A Kwakman; Arjan W Rauwers; Jolanda G Buijs; Woutrinus de Groot; Margreet C Vos; Marco J Bruno
Journal:  Endosc Int Open       Date:  2022-09-14

5.  Evaluation of an overnight non-culture test for detection of viable Gram-negative bacteria in endoscope channels.

Authors:  Harminder Singh; Donald R Duerksen; Gale Schultz; Carol Reidy; Pat DeGagne; Nancy Olson; Zoann Nugent; Michelle J Alfa
Journal:  Endosc Int Open       Date:  2019-01-30

Review 6.  A narrative review on current duodenoscope reprocessing techniques and novel developments.

Authors:  Maarten Heuvelmans; Herman F Wunderink; Henny C van der Mei; Jan F Monkelbaan
Journal:  Antimicrob Resist Infect Control       Date:  2021-12-23       Impact factor: 4.887

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.